Exclusive Partnership for Anti Microbial Resistant Anti-infective Drug


Client

Research Driven Publicly listed Company


Client Need

Find a suitable US partner to take FDA approvals and market their AMR Anti-infective drug, to exploit full market potential. 


Solution Approach

    • Aagami approached numerous companies and got 5 relevant companies interested. 
    • Discussion with 3 companies progressed to Due Diligence levels. 
    • Aagami also represented the client in various Trade Shows like BIO, J P Morgan, BIO Europe and Biotech Showcase; resulting in interested companies from Canada, Europe, Japan and Israel.
    • Facilitated entire evaluation and deal structuring process with prospective companies.
    • During the process Aagami ensured clear understanding despite socio cultural differences in styles of working.

    Results

    • Partnership established for Canada Market
    • Term sheet signed for US market

    ×
    Twitter